Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors

Details for Australian Patent Application No. 2007284690 (hide)

Owner Arubor Corporation

Inventors Levitt, Roy C.

Agent Allens Arthur Robinson

Pub. Number AU-A-2007284690

PCT Pub. Number WO2008/021237

Priority 60/836,760 10.08.06 US; 60/878,385 04.01.07 US; 60/907,028 16.03.07 US

Filing date 10 August 2007

Wipo publication date 21 February 2008

International Classifications

A61K 31/70 (2006.01) - Carbohydrates

C07H 21/02 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 5/00 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines

Event Publications

5 March 2009 PCT application entered the National Phase

  PCT publication WO2008/021237 Priority application(s): WO2008/021237

10 February 2011 Assignment before Grant

  Arubor Corporation The application has been assigned to Levitt, Roy

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007284699-Advertisement display device and method

2007284688-Process and intermediates for the synthesis of 2-(Quinolin-5-yl)-4,5 Disubstituted-Azole derivatives